Impact of the Fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X‐associated Tremor/Ataxia syndrome: A controlled study
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Fragile X Syndrome is the most common heritable form of mental retardation caused by silencing of the FMR1 gene, which arises from intergenerational trinucleotide repeat expansion leading to full mutation. An intermediary carrier condition, known as the premutation, is characterized by expansion up to 200 repeats without concomitant gene silencing. This prevalent allelic variant was initially thought to be free of phenotypic effects. However, recent reports have identified a degenerative disease, Fragile X‐associated Tremor/Ataxia Syndrome (FXTAS) in older men as well as premature ovarian failure in women. Previously reports are inconsistent regarding the neuropsychiatric phenotype associated with premutation due to small sample sizes, ascertainment bias, lack of adequate control groups, administration of measures with poor psychometric properties, and the confounding effects of FXTAS. We addressed these problems by conducting a controlled study of male carriers (n = 40) of the premutation without manifest symptoms of FXTAS, comparing their responses on specific, reliable, and valid measures of neuropsychiatric functioning to those of individuals with shared family environment (n = 22) and non‐carrier comparison males (n = 43). Multivariate analyses revealed that the premutation confers significant risk for working memory difficulties, an associated feature of Attention‐Deficit Disorder. Furthermore, both the family controls and men with premutation exhibited higher rates of Alcohol Abuse as compared to non‐carrier control men. These findings highlight the importance of recognizing the distinct phenotypic outcomes that characterize the Fragile X premutation and the subtle risk factors that can act as precursors to more significant psychiatric impairment. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baron-Cohen, S., Wheelwright, S., Skinner, R., Martin, J., & Clubley, E. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005653411471 · Cited by 6,450 · cited 1×
“The Autism Spectrum Quotient (AQ) is a self-report screening tool designed to obtain an estimate of the degree to which an individual of average intelligence manifests autistic traits [Baron-Cohen et al., 2001].”
MethodVerkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481 · cited 2×
“…(CGG)n repeat region within the 50 untranslated region of the Fragile X Mental Retardation 1 (FMR1) gene (Online Mendelian Inheritance in Man1 [OMIM] 309550; John’s Hopkins University, Baltimore, MD) located on the X chromosome [Oberle et al., 1991; Pieretti et al., 1991; Verkerk et al., 1991].”
BackgroundLiebowitz, M. R. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000414022 · Cited by 2,266
The SPQ: A Scale for the Assessment of Schizotypal Personality Based on DSM-III-R Criteria
Raine, A. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.4.555 · Cited by 2,164
Instability of a 550-Base Pair DNA Segment and Abnormal Methylation in Fragile X Syndrome
Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boué, J., Bertheas, M. F., & Mandel, J. L. (1991) · Science · doi:10.1126/science.252.5009.1097 · Cited by 1,499
Absence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
Brown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109 · cited 1×
“This is a reasonable assumption because FMRP acts as an mRNA chaperone for a variety of genes [Brown et al., 2001] as well as a negative regulator of translation for the transcripts to which it binds [Laggerbauer et al., 2001].”
BackgroundFRESCO, D. M., COLES, M. E., HEIMBERG, R. G., LIEBOWITZ, M. R., HAMI, S., STEIN, M. B., & GOETZ, D. (2001) · Psychological Medicine · doi:10.1017/s0033291701004056 · Cited by 874 · cited 2×
“The internal consistency for the various subscales of the LSAS, as measured by coefficient alpha, in both clinical and nonclinical samples ranges from 0.73 for the Avoidance of Performance subscale to 0.91 for the Total Fear score [Fresco et al., 2001].”
BackgroundMethodInfluentialWoodbury-Smith, M. R., Robinson, J., Wheelwright, S., & Baron-Cohen, S. (2005) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-005-3300-7 · Cited by 771
The Collaborative Longitudinal Personality Disorders Study: Reliability of Axis I and II Diagnoses
Zanarini, M. C., Skodol, A. E., Bender, D., Dolan, R., Sanislow, C., Schaefer, E., Morey, L. C., Grilo, C. M., Shea, M. T., McGlashan, T. H., et al. (2000) · Journal of Personality Disorders · doi:10.1521/pedi.2000.14.4.291 · Cited by 771 · cited 1×
“Furthermore, both test-retest and interrater reliability for this instrument are extremely good [Zanarini et al., 2000; Zanarini and Frankenburg, 2001].”
MethodFMR1 and the fragile X syndrome: Human genome epidemiology review
Crawford, D. C., Acuña, J. M., & Sherman, S. L. (2001) · Genetics in Medicine · doi:10.1097/00125817-200109000-00006 · Cited by 711 · cited 1×
“Fragile X syndrome (FXS) has been identified as the most common heritable form of mental retardation affecting nearly 1 in 4,000 males and 1 in 9,000 females [Turner et al., 1996; Crawford et al., 2001].”
BackgroundCognitive-perceptual, interpersonal, and disorganized features of schizotypal personality
Raine, A., Reynolds, C., Lencz, T., Scerbo, A., Triphon, N., & Kim, D. (1994) · Schizophrenia Bulletin · doi:10.1093/schbul/20.1.191 · Cited by 595 · cited 1×
“Confirmatory factor analysis reveals that the SPQ has three underlying factors, which are, cognitive-perceptual deficits, interpersonal deficits, and disorganized behavior [Raine et al., 1994].”
BackgroundEvidence that fragile X mental retardation protein is a negative regulator of translation
Laggerbauer, B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.4.329 · Cited by 571
Zanarini, M. C., & Frankenburg, F. R. (2001) · Comprehensive Psychiatry · doi:10.1053/comp.2001.24556 · Cited by 384
FARZIN, F., PERRY, H., HESSL, D., LOESCH, D., COHEN, J., BACALMAN, S., GANE, L., TASSONE, F., HAGERMAN, P., & HAGERMAN, R. (2006) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200604002-00012 · Cited by 325 · cited 4×
“Briefly, studies have been limited by small sample sizes [Thompson et al., 1994; Myers et al., 2001; Aziz et al., 2003; Goodlin-Jones et al., 2004; Farzin et al., 2006], ascertainment bias [e.g., Aziz et al., 2003] failure to differentiate between FXTAS affected and non-carrier individuals [e.g.,…”
BackgroundInfluentialSelf-citationDombrowski, C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.4.371 · Cited by 289 · cited 2×
“Elucidating this putative profile is critically important because unlike the full mutation, prevalence of the premutation is relatively high, estimated at affecting 1 in 813 men [Dombrowski et al., 2002] and 1 in 259 women [Rousseau et al.”
BackgroundBacalman, S., Farzin, F., Bourgeois, J. A., Cogswell, J., Goodlin-Jones, B. L., Gane, L. W., Grigsby, J., Leehey, M. A., Tassone, F., & Hagerman, R. J. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0112 · Cited by 175 · cited 1×
“…focused on non-symptomatic carriers (i.e., without FXTAS) to guard against the potential confound of a medical illness, which is known to deleteriously impact brain function [Bacalman et al., 2006] and thereby, result in the manifestation of psychiatric/psychological problems secondary to FXTAS.”
BackgroundSelf-citationThe emerging fragile X premutation phenotype: Evidence from the domain of social cognition
Cornish, K., Kogan, C., Turk, J., Manly, T., James, N., Mills, A., & Dalton, A. (2005) · Brain and Cognition · doi:10.1016/j.bandc.2004.08.020 · Cited by 148 · cited 4×
“…[Dorn et al., 1994; Aziz et al., 2003], anxiety [Dorn et al., 1994; Aziz et al., 2003; Hessl et al., 2005], symptoms of psychoticism [Hessl et al., 2005], and behaviors associated with the autistic spectrum [Aziz et al., 2003; Goodlin-Jones et al., 2004; Cornish et al., 2005; Farzin et al., 2006].”
BackgroundInfluentialSelf-citation
Cited by
Fragile X-Associated Neuropsychiatric Disorders (FXAND)
Hagerman, R. J., Protic, D., Rajaratnam, A., Salcedo-Arellano, M. J., Aydin, E. Y., & Schneider, A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00564 · Cited by 204
Self-citationTurk, J. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328349bb77 · Cited by 35
Self-citationWinarni, T. I., Aishworiya, R., Culpepper, H., Zafarullah, M., Mendoza, G., Wilaisakditipakorn, T. J., Likhitweerawong, N., Law, J., Hagerman, R., & Tassone, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072840 · Cited by 3
“Alcohol use disorder is more common in males who carry the premutation (55–200 CGG repeats) as compared to the general population, possibly due to attempts to self-treat neuropsychiatric conditions like depression and anxiety [34].”
Self-citation
Metadata
- Authors
- Kogan, C. S., Turk, J., Hagerman, R. J., & Cornish, K. M.
- Venue
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Publisher
- Wiley
- Published
- 2008-08-22
- Volume
- 147B
- Issue
- 6
- Pages
- 859-872
- ISSN
- 1552-4841 (ISSN-L)
- 1552-485X
- OpenAlex
- W2117988450
- Cited by
- 69
- References
- 18
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.